Advertisement

Citation tools

Ali, Haris et al "MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen." Blood Advances 3.1 (2019): 83-95. Web. 22 May. 2019.